Risk factors for age-related maculopathy in a 14-year follow-up study: The Copenhagen City Eye Study

Acta Ophthalmologica Scandinavica

Volumn 83, Issue 4, 2005, Pages 409-418

  Buch, Helena ^a   Vinding, Troels ^a   la Cour, Morten ^b   Jensen, Gorm B ^c,d   Prause, Jan U ^a   Nielsen, Niels V ^a  

^a Rigshospitalet   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c BISPEBJERG HOSPITAL   (Denmark)

^d HVIDOVRE HOSPITAL   (Denmark)

Author keywords

Age related maculopathy; AMD; ARM; Incidence; Risk factors

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B;

ADULT; AGE DISTRIBUTION; AGED; ALCOHOL CONSUMPTION; ARTICLE; CATARACT; CLINICAL PROTOCOL; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DEATH; DENMARK; EYE FUNDUS; EYE PHOTOGRAPHY; FAMILY HISTORY; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PHYSICAL EXAMINATION; POPULATION RESEARCH; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; RISK ASSESSMENT; STANDARDIZATION; SURVIVAL RATE; UNIVERSITY HOSPITAL; VISUAL SYSTEM EXAMINATION; VOLUNTEER;

AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; DENMARK; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MACULAR DEGENERATION; MALE; MIDDLE AGED; ODDS RATIO; RISK FACTORS; SEX DISTRIBUTION;

EID: 21044449290     PISSN: 13953907     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0420.2005.00492.x     Document Type: Article

References (82)

1. Age-related Eye Disease Study Group (2001): A randomized, placebo-controlled clinical trial of high dose supplementation with vitamins C and E, beta carotene and zinc for age-related macular degeneration and vision loss. Arch Ophthalmol 119: 1417-1436.
2. Age-related Eye Disease Study Research Group (2000): Risk factors associated with age-related macular degeneration. A case-control study in the Age-related Eye Disease Study. Age-related Eye Disease Study Report No. 3. Ophthalmology 107: 2224-2232.
3. Allikmets R (2000a): Further evidence for an association of ABCR alleles with age-related macular degeneration. The International ABCR Screening Consortium. Am J Hum Genet 67: 487-491.
4. Allikmets R (2000b): Simple and complex ABCR: genetic predisposition to retinal disease. Am J Hum Genet 67: 793-799.
5. Appleyard M, Hansen AT, Jensen G et al. (1989): The Copenhagen City Heart Study. Øterbroundersøgelsen. A book of tables with data from the first examination (1976-78) and a 5-year follow-up (1981-83). The Copenhagen City Heart Study Group. Scand J Soc Med 41 (Suppl).
6. Baird PN, Guida E, Chu DT et al. (2004): The ε2 and ε4 alleles of the apolipoprotein gene are associated with age-related macular degeneration. Invest Ophthalmol Vis Sci 45: 1311-1315.
7. Bellows JG (1971): Light: a double-edged sword. Ann Ophthalmol 3: 687-688.
8. Borger PH, van Leeuwen R, Hulsman CAA et al. (2003): Is there a direct association between age-related eye diseases and mortality? Ophthalmology 110: 1292-1296.
9. Bressler NM, Munoz B, Maguire MG et al. (1995): Five-year incidence and disappearance of drusen and retinal pigment epithelial abnormalities. Waterman Study. Arch Ophthalmol 113: 301-308.
10. Buch H, Nielsen NV, Vinding T et al. (2005a): The 14-year incidence, progression and visual morbidity of age-related maculopathy. The Copenhagen City Eye Study. Ophthalmology 112: 787-798.
11. Buch H, Vinding T, la Cour M et al. (2005b): Age-related maculopathy: a risk indicator for poorer survival in women. The Copenhagen City Eye Study. Ophthalmology 112: 305-312.
12. Buch H, Vinding T, la Cour M & Nielsen NV (2001a): The prevalence and causes of bilateral and unilateral blindness in an elderly urban Danish population. The Copenhagen City Eye Study. Acta Ophthalmol Scand 79: 441-449.
13. Buch H, Vinding T & Nielsen NV (2001b): Prevalence and causes of visual impairment according to World Health Organization and United States criteria in an aged, urban Scandinavian population: the Copenhagen City Eye Study. Ophthalmology 108: 2347-2357.
14. Chaine G, Hullo A, Sahel J et al. (1998): Case-control study of the risk factors for age-related macular degeneration. France-DMLA Study Group. Br J Ophthalmol 82: 996-1002.
15. Cho E, Hankinson SE, Willett WC et al. (2000): Prospective study of alcohol consumption and the risk of age-related macular degeneration. Arch Ophthalmol 118: 681-688.
16. Cruickshanks KJ, Klein R & Klein BE (1993): Sunlight and age-related macular degeneration. The Beaver Dam Eye Study. Arch Ophthalmol 111: 514-518.
17. Cruickshanks KJ, Klein R, Klein BE & Nondahl DM (2001): Sunlight and the 5-year incidence of early age-related maculopathy. The Beaver Dam Eye Study. Arch Ophthalmol 119: 246-250.
18. Evans JR (2001): Risk factors for age-related macular degeneration. Prog Retin Eye Res 20: 227-253.
19. Eye Disease Case-control Study Group (1992): Risk factors for neovascular age-related macular degeneration. Arch Ophthalmol 110: 1701-1708.
20. Frikke-Schmidt R (2000): Context-dependent and invariant associations between APOE genotype and levels of lipoproteins and risk of ischaemic heart disease: a review. Scand J Clin Lab Invest 60: 3-26.
21. Frikke-Schmidt R, Nordestgaard BG, Agerholm-Larsen B et al. (2000a): Context-dependent and invariant associations between lipids, lipoproteins and apolipoproteins and apolipoprotein E genotype. J Lipid Res 41: 1812-1822.
22. Frikke-Schmidt R, Tybjærg-Hansen A, Steffensen R et al. (2000b): Apolipoprotein E genotype: ε32 women are protected while ε43 and ε44 men are susceptible to ischaemic heart disease. The Copenhagen City Heart Study. J Am Coll Cardiol 35: 1192-1199.
23. Goldberg J, Flowerdew G, Smith E et al. (1988): Factors associated with age-related macular degeneration. An analysis of data from the first National Health and Nutrition Examination Survey. Am J Epidemiol 128: 700-710.
24. Gorin MB, Breitner JC, de Jong PT et al. (1999): The genetics of age-related macular degeneration. Mol Vis 5: 29.
25. Heiba IM, Elston RC, Klein BEK & Klein R (1993): Genetic aetiology of nuclear cataract: evidence for a major gene. Am J Med Genet 47: 1208-1214.
26. Heiba IM, Elston RC, Klein BE & Klein R (1994): Sibling correlations and segregation analysis of age-related maculopathy: the Beaver Dam Eye Study. Genet Epidemiol 11: 51-67.
27. Hirvela H, Luukinen H, Laara E et al. (1996): Risk factors of age-related maculopathy in a population 70 years of age or older. Ophthalmology 103: 871-877.
28. Hyman LG, Lilienfeld AM, Ferris FL III & Fine SL (1983): Senile macular degeneration: a case-control study. Am J Epidemiol 118: 213-227.
29. de Jong PT, Bergen AA, Klaver CC et al. (2001): Age-related maculopathy: its genetic basis. Eye 15: 396-400.
30. de Jong PT, Klaver CC, Wolfs RC et al. (1997): Familial aggregation of age-related maculopathy. Am J Ophthalmol 124: 862-863.
31. Kahn HA, Leibowitz HM, Ganley JP et al. (1977): The Framingham Eye Study. II. Association of ophthalmic pathology with single variables previously measured in the Framingham Heart Study. Am J Epidemiol 106: 33-41.
32. Katz ML, Parker KR, Handelman GJ et al. (1982): Effects of antioxidant nutrient deficiency on the retina and retinal pigment epithelium of albino rats: a light and electron microscopic study. Exp Eye Res 34: 339-369.
33. Klaver CC, Assink JJ, van Leeuwen R et al. (2001): Incidence and progression rates of age-related maculopathy: the Rotterdam Study. Invest Ophthalmol Vis Sci 42: 2237-2241.
34. Klaver CC, Kliffen M, Van Duijn CM et al. (1998a): Genetic association of apolipoprotein E with age-related macular degeneration. Am J Hum Genet 63: 200-206.
35. Klaver CC, Wolfs RC, Assink JJ et al. (1998b): Genetic risk of age-related maculopathy. Population-based familial aggregation study. Arch Ophthalmol 116: 1646-1651.
36. Klein R, Davis MD, Magli YL et al. (1991): The Wisconsin Age-related Maculopathy Grading System. Ophthalmology 98: 1128-1134.
37. Klein R, Klein BE & Franke T (1993): The relationship of cardiovascular disease and its risk factors to age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology 100: 406-414.
38. Klein R, Klein BE & Jensen SC (1997a): The relation of cardiovascular disease and its risk factors to the 5-year incidence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology 104: 1804-1812.
39. Klein R, Klein BE, Jensen SC & Cruickshanks KJ (1998b): The relationship of ocular factors to the incidence and progression of age-related maculopathy. Arch Ophthalmol 116: 506-513.
40. Klein R, Klein BE, Jensen SC et al. (1999): Age-related maculopathy in a multiracial United States population: the National Health and Nutrition Examination Survey III. Ophthalmology 106: 1056-1065.
41. Klein R, Klein BE, Jensen SC & Meuer SM (1997b): The 5-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology 104: 7-21.
42. Klein R, Klein BE & Moss SE (1995): Age-related eye disease and survival. The Beaver Dam Eye Study. Arch Ophthalmol 113: 333-339.
43. Klein R, Klein BE, Tomany SC & Cruickshanks KJ (2003): The association of cardiovascular disease with the long-term incidence of age-related maculopathy. Ophthalmology 110: 636-643.
44. Klein R, Klein BE, Tomany SC et al. (2002a): Ten-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology 109: 1767-1779.
45. Klein R, Klein BE, Tomany SC & Moss SE (2002b): Ten-year incidence of age-related maculopathy and smoking and drinking: the Beaver Dam Eye Study. Am J Epidemiol 156: 589-598.
46. Klein R, Klein BEK, Wang Q & Moss SE (1994): Is age-related maculopathy associated with cataracts? Arch Ophthalmol 112: 191-196.
47. Klein R, Klein BE, Wong TY et al. (2002c): The association of cataract and cataract surgery with the longterm incidence of age-related maculopathy: the Beaver Dam Eye Study. Arch Ophthalmol 120: 1551-1558.
48. Klein ML, Schultz DW, Edwards A et al. (1998a): Age-related macular degeneration: clinical features in a large family and linkage to chromosome 1q. Arch Ophthalmol 116: 1082-1088.
49. van Leeuwen R, Klaver CC, Vingerling JR et al. (2003): The risk and natural course of age-related maculopathy: follow-up at 6 1/2 years in the Rotterdam Study. Arch Ophthalmol 121: 519-526.
50. van Leeuwen R, Klaver CC, Vingerling JR et al. (2004): Cholesterol and age-related macular degeneration: is there a link? Am J Ophthalmol 137: 750-752.
51. Linn S, Carroll M, Johnson C et al. (1993): High density lipoprotein cholesterol and alcohol consumption in US white and black adults: data from NHANES II. Am J Public Health 83: 811-816.
52. Maltzman BA, Mulvihill MN & Greenbaum A (1979): Senile macular degeneration and risk factors: a case-control study. Ann Ophthalmol 11: 1197-1201.
53. Manninen V, Elo MO, Frick H et al. (1988): Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study. JAMA 260: 641-651.
54. Mares-Perlman JA, Brady WE, Klein BEK et al. (1995): Diet and nuclear lens opacities. Am J Epidemiol 141: 322-334.
55. Mares-Perlman JA, Klein R, Klein BE et al. (1996): Association of zinc and antioxidant nutrients with age-related maculopathy. Arch Ophthalmol 114: 991-997.
56. McCarty CA, Mukesh BN, Fu CL et al. (2001): Risk factors for age-related maculopathy: the Visual Impairment Project. Arch Ophthalmol 119: 1455-1462.
57. Meyers SM (1994): A twin study on age-related macular degeneration. Trans Am Ophthalmol Soc 92: 775-843.
58. Mitchell P, Wang JJ, Foran S & Smith W (2002): Five-year incidence of age-related maculopathy lesions: the Blue Mountains Eye Study. Ophthalmology 109: 1092-1097.
59. Moss SE, Klein R, Klein BE et al. (1998): Alcohol consumption and the 5-year incidence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology 105: 789-794.
60. Rikans LE & Gonzalez LP (1990): Antioxidant protection systems of rat lung after chronic ethanol inhalation. Alcohol Clin Exp Res 14: 872-877.
61. Rosenblum ER, Gavaler JS & Van Thiel DH (1989): Lipid peroxidation: a mechanism for alcohol-induced testicular injury. Free Radic Biol Med 7: 569-577.
62. Rothman KJ (1990): No adjustments are needed for multiple comparisons. Epidemiology 1: 43-46.
63. Schnohr P, Jensen G, Lange P et al. (2001): The Copenhagen City Heart Study. Øterbroundersøgelsen. Tables with data from the third examination 1991-94. Eur Heart J 3 (Suppl): 1-83.
64. Schnohr P, Jensen G, Nyboe J & Tybjærg HA (1977): The Copenhagen City Heart Study. A prospective cardiovascular population study of 20 000 men and women. Ugeskr Laeger 139: 1921-1923.
65. Seddon JM, Ajani UA & Mitchell BD (1997): Familial aggregation of age-related maculopathy. Am J Ophthalmol 123: 199-206.
66. Silvestri G, Johnston PB & Hughes AE (1994): Is genetic predisposition an important risk factor in age-related macular degeneration? Eye 8: 564-568.
67. Smith W, Assink J, Klein R et al. (2001): Risk factors for age-related macular degeneration: pooled findings from three continents. Ophthalmology 108: 697-704.
68. Smith W & Mitchell P (1996): Alcohol intake and age-related maculopathy. Am J Ophthalmol 122: 743-745.
69. Smith W & Mitchell P (1998): Family history and age-related maculopathy: the Blue Mountains Eye Study. Aust N Z J Ophthalmol 26: 203-206.
70. Smith W, Mitchell P, Leeder SR & Wang JJ (1998): Plasma fibrinogen levels, other cardiovascular risk factors and age-related maculopathy: the Blue Mountains Eye Study. Arch Ophthalmol 116: 583-587.
71. Souied EH, Benlian P, Amouyel P et al. (1998): The ε4 allele of the apolipoprotein E gene as a potential protective factor for exudative age-related macular degeneration. Am J Ophthalmol 125: 353-359.
72. Sparrow JM, Dickinson AJ, Duke AM et al. (1997): Seven-year follow-up of age-related maculopathy in an elderly British population. Eye 11: 315-324.
73. Sperduto RD, Hiller R & Seigel D (1981): Lens opacities and senile maculopathy. Arch Ophthalmol 99: 1004-1008.
74. Taylor HR, McCarty CA & Nanjan MB (2000): Vision impairment predicts 5-year mortality. Trans Am Ophthalmol Soc 98: 91-99.
75. Tomany SC, Wang JJ, van Leeuwen R et al. (2004): Risk factors for incident age-related macular degeneration. Pooled findings from three continents. Ophthalmology 111: 1280-1287.
76. Tuo J, Bojanowski CM & Chan CC (2004): Genetic factors of age-related macular degeneration. Prog Retin Eye Res 23: 229-249.
77. Vinding T (1995): Age-related macular degeneration. An epidemiological study of 1000 elderly individuals with reference to prevalence, funduscopic findings, visual impairment and risk factors. Acta Ophthalmol Scand 218 (73): 1-32.
78. Vinding T, Appleyard M, Nyboe J & Jensen G (1992): Risk factor analysis for atrophic and exudative age-related macular degeneration. An epidemiological study of 1000 aged individuals. Acta Ophthalmol (Copenh) 70: 66-72.
79. Wang JJ, Klein R, Smith W et al. (2003): Cataract surgery and the 5-year incidence of late-stage age-related maculopathy: pooled findings from the Beaver Dam and Blue Mountains Eye Studies. Ophthalmology 110: 1960-1967.
80. Wang JJ, Mitchell P, Simpson JM et al. (2001): Visual impairment, age-related cataract and mortality. Arch Ophthalmol 119: 1186-1190.
81. West SK, Rosenthal FS, Bressler NM et al. (1989): Exposure to sunlight and other risk factors for age-related macular degeneration. Arch Ophthalmol 107: 875-879.
82. Zareparsi S, Reddick AC, Branham KE et al. (2004): Association of apolipoprotein E alleles with susceptibility to age-related macular degeneration in a large cohort from a single centre. Invest Ophthalmol Vis Sci 45: 1306-1310.